This document lists the medicines eligible for supply through the Northern Ireland MHRA Authorised Route (NIMAR).
The listed medicines may be dispatched from Great Britain to Northern Ireland on the basis of the medicines authorisation in Great Britain.
This list is maintained and published in accordance with regulation 167B (list of NIMAR products) of the Human Medicines Regulations 2012 (SI 2012/1916, as amended).
Updates to this page
Published 16 December 2021 Last updated 29 November 2024 +show all updates
Updated to add items to the list and to correct one item. Added: Zubsolv 1.4mg/0.36mg sublingual tablets - Buprenorphine 1.4mg / Naloxone 360microgram sublingual tablets sugar free; Zubsolv 2.9mg/0.71mg sublingual tablets - Buprenorphine 2.9mg / Naloxone 710microgram sublingual tablets sugar free; Zubsolv 5.7mg/1.4mg sublingual tablets - Buprenorphine 5.7mg / Naloxone 1.4mg sublingual tablets sugar free; and Zubsolv 8.6mg/2.1mg sublingual tablets - Buprenorphine 8.6mg / Naloxone 2.1mg sublingual tablets sugar free. Corrected: 'Methotrexate 15mg/0.3ml solution for injection pre-filled syringes' to 'Methotrexate 15mg/0.3ml solution for injection pre-filled pens'.
Updated to add and remove products from the list: Added: Vegzelma 100mg/4ml concentrate for solution for infusion vials - Bevacizumab 100mg/4ml solution for infusion vials; and Vegzelma 400mg/16ml concentrate for solution for infusion vial - Bevacizumab 400mg/16ml solution for infusion vials. Removed: Levemir Innolet 100 units/ml solution for injection 3 ml pre filled pens - Insulin Detemir 100 units/ml solution for injection 3ml pre filled disposable devices; and Insulatard Innolet 100 units/ml suspension for injection 3ml pre filled pen - Insulin Isophane human 100 units/ml suspension for injection 3 ml pre filled disposable devices.
Updated to add the following products: Quetiapine 50mg modified-release tablets; Quetiapine 150mg modified-release tablets; Quetiapine 200mg modified-release tablets; Quetiapine 300mg modified-release tablets; Quetiapine 400mg modified-release tablets; and Vinorelbine 10mg/1ml concentrate for solution for infusion vials.
Updated to add and remove products from the list. Added: Methotrexate 15mg/0.3ml solution for injection pre-filled syringes; Neratinib 40mg tablets; Vimpat 150mg tablets - Lacosamide 150mg tablets; Voriconazole 200mg/5ml oral suspension; Lorlatinib 100mg tablets; Vyloy 100mg powder for concentrate for solution for infusion vials - Zolbetuximab 100mg powder for solution for infusion vials; and Entresto 15mg/16mg granules in capsules for opening - Sacubitril 15mg/Valsartan 16mg granules in capsules for opening. Removed: Zonegran 50mg capsules - Zonisamide 50mg capsules.
Updated to add: Methylthioninium chloride (methylene blue) 50mg/10ml solution for injection ampoules.
Updated to add: Ayvakyt 200mg tablets - Avapritinib 200mg tablets.
Updated to add and remove products from the list. Added: Methotrexate 7.5mg/0.75ml solution for injection pre-filled syringes; Methotrexate 20mg/2ml solution for injection pre-filled syringes; Fluorouracil 2.5g/50ml solution for infusion vials; and Elfabrio 5mg/2.5ml concentrate for solution for infusion vials (Pegunigalsidase alfa 5mg/2.5ml solution for infusion vials). Removed: Doxorubicin 2mg/ml concentrate for solution and Temodal 100mg capsules (Temozolomide 100mg capsules).
Added: Flucloxacillin 1g powder for solution for injection vials.
Added: Artesunate 110 mg powder and solvent for solution for injection vials.
Updated to add products to the list. Added Riociguat 2mg tablets; Riociguat 2.5mg tablets; Zanamivir 200mg/20ml solution for infusion vials.
Updated to add: Doxorubicin 2mg/ml concentrate for solution.
Updated to add and remove products from the list. Added: Cresemba 200mg powder for concentrate for solution for infusion vials - Isavuconazole 200mg powder for solution for infusion vials. Removed: Comirnaty Omicron XBB.1.5 COVID-19 mRNA Vaccine 30micrograms/0.3ml dose dispersion for injection single dose vials; and HyQvia 2.5g/25ml solution for infusion and 1.25ml vials - Normal immunoglobulin human 2.5g/25ml solution for infusion vials and Recombinant human hyaluronidase solution for infusion 1.25ml vials.
